Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AE04621 in Parkinson's Disease
NCT02649608Phase 1Completed
- Sponsor
- Lundbeck
- Start
- Jan 2016
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 1, open-label trial of Lu AE04621 in Parkinson's disease (PD), sponsored by Lundbeck. Started Jan 2016; status: completed.
02
Drugs
Lu AE04621
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02649608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649608.